RESUMEN
BACKGROUND: Medtronic is developing an atrial Micra Transcatheter Pacing System (Medtronic, Minneapolis, Minnesota) and associated retrieval system. OBJECTIVE: The purpose of this study was to evaluate chronic atrial Micra retrieval, reimplantation, and chronic pacing performance. METHODS: Sheep were implanted in 2 groups: group 1 (n = 6) for 6 months, a second device implanted, and first retrieved and studied for an additional 6 months; group 2 (n = 6) for 6 months, devices were retrieved, and a second device implanted and observed acutely. Both groups underwent histopathological evaluation. Pacing capture thresholds (PCTs), p wave amplitude, and pacing impedances were measured chronically. Device retrieval times were recorded, and intracardiac echocardiography was used. RESULTS: At 24 weeks, PCTs for group 1 were low and stable for both the first device (0.55 ± 0.14 V) and the second device (0.57 ± 0.09 V), in which the average retrieval time was 17:35 minutes. For group 2, the average retrieval time was 6:12 minutes, chronic PCTs in the first device were 0.53 ± 0.11 V, and acute PCTs for the second device were 0.71 ± 0.19 V. Pathological findings were within an expected range of tissue responses for similar Micra acute and chronic implants and device retrievals. p waves and impedances were stable and within an expected range for implant site and electrode design. Complications included 1 early dislodgment and 1 death attributed to a prototype retrieval tool. CONCLUSION: In an animal model, an atrial Micra can be easily implanted with excellent chronic pacing performance and is easily retrievable at 6 months. A second device can successfully be implanted with low, chronic stable thresholds. A developed prototype retrieval tool was easy to use and, with modifications, complication free.
